日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Valine-Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular Carcinoma.

缬氨酸-尼克酰胺用于治疗雄激素受体剪接变异体阳性肝细胞癌

Hoelzen Emma J, Radomska Hanna S, Kulp Samuel K, Adeluola Adeoluwa A, Granchie Lauren A, Cheng Jeffrey, Dauki Anees M, Campbell Moray J, Mohammed Shabber, Xing Enming, Hai Min, Fukuda Mayu, Cheng Xiaolin, Phelps Mitch A, Li Pui-Kai, Coss Christopher C

Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors

GS-3583(一种FMS样酪氨酸激酶3激动剂Fc融合蛋白)在晚期实体瘤患者中的I期研究

Tolcher, Anthony W; Brody, Joshua D; Rajakumaraswamy, Nishanthan; Kuhne, Michelle; Trowe, Torsten; Dauki, Anees M; Pai, Shantheri; Han, Ling; Lin, Kai-Wen; Petrarca, Michael; Kummar, Shivaani

Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participants

GS-3583(一种FLT3激动剂Fc融合蛋白)在健康受试者中单次递增剂量I期研究中的药代动力学、药效学和安全性

Dauki, Anees M; Rajakumaraswamy, Nishanthan; Trowe, Torsten; Weng, Winnie; Lin, Kai-Wen; Elboudjwarej, Emon; Qin, Ann Ran-Ran; Schwabe, Christian; Kuhne, Michelle R; Othman, Ahmed A

Phase 2 study of ibrutinib in classic and variant hairy cell leukemia

伊布替尼治疗经典型和变异型毛细胞白血病的 II 期研究

Rogers, Kerry A; Andritsos, Leslie A; Wei, Lai; McLaughlin, Eric M; Ruppert, Amy S; Anghelina, Mirela; Blachly, James S; Call, Timothy; Chihara, Dai; Dauki, Anees; Guo, Ling; Ivy, S Percy; James, Lacey R; Jones, Daniel; Kreitman, Robert J; Lozanski, Gerard; Lucas, David M; Ngankeu, Apollinaire; Phelps, Mitch; Ravandi, Farhad; Schiffer, Charles A; Carson, William E; Jones, Jeffrey A; Grever, Michael R

Approaches to handling missing or "problematic" pharmacology data: Pharmacokinetics

处理缺失或“有问题的”药理学数据的方法:药代动力学

Irby, Donald J; Ibrahim, Mustafa E; Dauki, Anees M; Badawi, Mohamed A; Illamola, Sílvia M; Chen, Mingqing; Wang, Yuhuan; Liu, Xiaoxi; Phelps, Mitch A; Mould, Diane R

Transcriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma Progression

转录活性雄激素受体剪接变体促进肝细胞癌进展

Anees M Dauki, James S Blachly, Esko A Kautto, Sameera Ezzat, Mohamed H Abdel-Rahman, Christopher C Coss

Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor

使用 HDAC 抑制剂克服实验性癌症恶病质对合成代谢 SARM 疗法的抵抗力

Sophia G Liva, Yu-Chou Tseng, Anees M Dauki, Michael G Sovic, Trang Vu, Sally E Henderson, Yi-Chiu Kuo, Jason A Benedict, Xiaoli Zhang, Bryan C Remaily, Samuel K Kulp, Moray Campbell, Tanios Bekaii-Saab, Mitchell A Phelps, Ching-Shih Chen, Christopher C Coss

Pharmacokinetic-Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High-Dose Melphalan for Autologous Stem Cell Transplant

接受高剂量美法仑自体干细胞移植的多发性骨髓瘤患者中性粒细胞减少症的药代动力学-药效学模型

Cho, Yu Kyoung; Irby, Donald J; Li, Junan; Sborov, Douglas W; Mould, Diane R; Badawi, Mohamed; Dauki, Anees; Lamprecht, Misty; Rosko, Ashley E; Fernandez, Soledad; Hade, Erinn M; Hofmeister, Craig C; Poi, Ming; Phelps, Mitch A

CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128

CD44 阳性且对索拉非尼不敏感的肝细胞癌对 ATP 竞争性 mTOR 抑制剂 INK128 有反应

Mohamed Badawi #, Jihye Kim #, Anees Dauki, Dhruvitkumar Sutaria, Tasneem Motiwala, Ryan Reyes, Nissar Wani, Shamalatha Kolli, Jinmai Jiang, Christopher C Coss, Samson T Jacob, Mitch A Phelps, Thomas D Schmittgen

Pharmacogenomics of statins: understanding susceptibility to adverse effects

他汀类药物的药物基因组学:了解不良反应的易感性

Kitzmiller, Joseph P; Mikulik, Eduard B; Dauki, Anees M; Murkherjee, Chandrama; Luzum, Jasmine A